drugset / Trial / NCT04688580

Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers

NCT04688580 ↗

Phase 0 Completed 46 enrolled XWPharma
NaSingle-groupOpen-labelOther

Summary

The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics of various formulations of XW10172 in healthy volunteers.

Timeline

Start
2020-11-29
Primary completion
2021-12-14
Completion
2021-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Valiloxybate Small molecule — Oral

Indications

No indication recorded.